InsiderClue
← All stocks

Immunome Inc.

IMNM Net buying
CIK 0001472012 #1696 in the set updated 17 Sep 2026
Bought (120 mo)
$12.77M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$27.79M
$18.48M on a plan · $7.77M straight out of an exercise
Sold at will
$1.54M
4 of 30 sales
Net
−$15.02M
+$11.23M against sales at will

By person

19 insiders · 75 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Barchas Isaac
Director
—
$18.27M (12) scheduled
−$18.27M
92,211
0.0812%
$2.33M
−89.7%
SIEGALL CLAY B
President and CEO
$7.26M (11)
—
+$7.26M
870,704
0.7666%
$22.05M
+478.8%
RAPP MICHAEL
Director
$3.33M (8)
—
+$3.33M
1,416,744
1.25%
$35.87M
+271.7%
Rosett Max
Chief Financial Officer
—
$2.75M (4) scheduled
−$2.75M
101,287
0.0892%
$2.56M
+410.1%
Horn Kinney
CHIEF BUSINESS OFFICER
—
$2.30M (2) scheduled
−$2.30M
0
0.0000%
$0.00
—
Lechleider Robert
Chief Medical Officer
$149.80K (1)
$2.34M (5) scheduled
−$2.19M
69,805
0.0615%
$1.77M
—
WAGENHEIM PHILIP
Director
$247.73K (1)
$1.34M (2)
−$1.09M
341,147
0.3004%
$8.64M
−11.1%
Higgins Jack
Chief Scientific Officer
—
$587.53K (3) scheduled
−$587.53K
60,250
0.0530%
$1.53M
+5,925%
Tsai Philip
Chief Technical Officer
$506.50K (3)
—
+$506.50K
81,550
0.0718%
$2.06M
—
BIENAIME JEAN JACQUES
Director
$641.23K (11)
$203.82K (2)
+$437.41K
43,415
0.0382%
$1.10M
+470.1%
Turner Bruce
Chief Strategy Officer
$249.99K (1)
—
+$249.99K
42,300
0.0372%
$1.07M
—
Sarma Purnanand D
President and CEO
$193.31K (1)
—
+$193.31K
10,500
0.0092%
$265.86K
—
LAMATTINA JOHN L
Director
$101.03K (2)
—
+$101.03K
66,953
0.0589%
$1.70M
—
Lefenfeld Michael
Director
$86.15K (3)
—
+$86.15K
40,747
0.0359%
$1.03M
—
MORRIS I WISTAR III
10% owner
—
—
—
920,939
0.8108%
$23.32M
—
PRENDERGAST FRANKLYN G
Director
—
—
—
60,840
0.0536%
$1.54M
—
Widlitz Michael
Director
—
—
—
51,315
0.0452%
$1.30M
—
Stoneman Sandra G.
CHIEF LEGAL OFFICER & GC
—
—
—
43,805
0.0386%
$1.11M
+688.6%
BARON RICHARD A
Director
—
—
—
2,343
0.0021%
$59.32K
—

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Higgins Jack
11 Sep 2026
Chief Scientific Officer
Sold after exercise
13,200
$25.32
$334.22K
Horn Kinney
4 Aug 2026
CHIEF BUSINESS OFFICER
Sold after exercise
90,616
$25.09
$2.27M
Horn Kinney
7 Jul 2026
CHIEF BUSINESS OFFICER
Sold after exercise
1,092
$25.00
$27.30K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,072
$23.44
$376.73K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,214
$22.76
$369.03K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
22,714
$21.95
$498.57K
Lechleider Robert
25 Jun 2026
Chief Medical Officer
Sold after exercise
14,420
$20.66
$297.92K
Lechleider Robert
25 Jun 2026
Chief Medical Officer
Sold after exercise
40,580
$19.56
$793.74K
Rosett Max
15 Jun 2026
Chief Financial Officer
Sold after exercise
60,000
$18.23
$1.09M
Rosett Max
2 Apr 2026
Chief Financial Officer
Sold after exercise
1,344
$22.48
$30.21K
Rosett Max
2 Apr 2026
Chief Financial Officer
Sold after exercise
63,656
$21.91
$1.39M
Rosett Max
19 Sep 2024
Chief Financial Officer
Sold after exercise
14,380
$16.01
$230.22K
Higgins Jack
15 Aug 2024
Chief Scientific Officer
Sold after exercise
3,524
$13.93
$49.07K
Show all 75 transactions →

What was left out

Form 4 filings counted 156
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 13
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 3,059,462
History held since 5 Oct 2020